Effects of the anti-receptor activator of nuclear factor kappa B ligand denusomab on beta thalassemia major-induced osteoporosis

INTRODUCTION: Osteoporosis represents the second most common cause of endocrinopathy in patients with beta thalassemia major (BTM). Some drugs proved effective to reduce vertebral and non-vertebral fracture risk. Denosumab is a fully human monoclonal antibody to the receptor activator of nuclear fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Yassin, Mohamed A., Soliman, Ashraf T., De Sanctis, Vincenzo, Abdelrahman, Mohamed Osman, Aziz Bedair, Elsaid M., AbdelGawad, Manal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138914/
https://www.ncbi.nlm.nih.gov/pubmed/25143915
http://dx.doi.org/10.4103/2230-8210.137516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138914/
https://www.ncbi.nlm.nih.gov/pubmed/25143915
http://dx.doi.org/10.4103/2230-8210.137516

Ejemplares similares